15 results

• Tagrisso, Lazcluze Side Effects Increase Heart Risks: Study

  September 30, 2025

  Martha Garcia

  A new study warns that third-generation EGFR inhibitor cancer drugs, such as Tagrisso and Lazcluze, may pose a higher risk of heart problems than earlier cancer therapies.

• Keytruda, Similar Cancer Drugs May Increase Risk of Pulmonary Embolism: Study

  October 17, 2024

  Martha Garcia

  New research indicates the use of certain cancer treatment drugs, like Keytruda and Opdivo, could pose a high risk of life-threatening cardiovascular events, adding to recent concerns about the class of medications.

• Most Cancer Drugs Granted Accelerated Approval Later Show Few Real-World Benefits: Study

  April 10, 2024

  Martha Garcia

  A new study's findings reveal that many cancer drugs that go through the FDA's accelerated approval program end up not being safe, effective, or fully vetted before being granted full approval for use by patients.

• Investigation Into CAR-T Cell Treatments Reveals New Data on Patient Deaths, Effectiveness

  December 13, 2023

  Katherine McDaniel

  A new study warns of a number of potential side effects and health risks linked to CAR-T drugs used to treat blood cancers like multiple myeloma,

• Multiple Myeloma Drug Side Effects Downplayed in Clinical Trials, Study Warns

  November 14, 2023

  Martha Garcia

  A new study warns that multiple myeloma drug clinical trials often downplay the severity of side effects and adverse results, Johns Hopkins researchers warn.

• Researchers Warn that Side Effects of Nexium, Prilosec and Other Heartburn Drugs May Interfere with Breast Cancer Treatments: Study

  July 25, 2023

  Irvin Jackson

  Researchers warn that the side effects of Nexium, Prilosec and similar heartburn drugs can interfere with certain cancer medications, resulting in lower survival rates for women with advanced breast cancer.

• Tecentriq and Avastin Liver Cancer Combo Linked to Patient Deaths in Early Trials

  April 18, 2023

  Martha Garcia

  Some patient deaths have been linked to a clinical trial using a combination of Tecentriq and Avastin to prevent the return of liver cancer.

• Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

  June 3, 2022

  Irvin Jackson

  The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.

• Tagrisso Side Effects Linked to Potentially Deadly Skin Reactions: Case Report

  May 3, 2022

  Irvin Jackson

  A case report warns of potentially extreme and deadly skin reactions linked to use of the cancer drug Tagrisso.

• Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

  February 4, 2022

  Irvin Jackson

  The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.